Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization–embryo transfer  Mohamed.

Slides:



Advertisements
Similar presentations
Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind,
Advertisements

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Complete septate uterus with longitudinal vaginal septum
Efficacy and tolerability of vaginal progesterone capsules (Utrogest™ 200) compared with progesterone gel (Crinone™ 8%) for luteal phase support during.
Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial  Juan.
Cryopreservation of supernumerary high quality embryos predicts favorable outcomes for patients undergoing repeated cycles of in vitro fertilization 
Endometrin as luteal phase support in assisted reproduction
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,
Michael M. Alper, M.D.  Fertility and Sterility 
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
Conservative management of cervical ectopic pregnancy
Early loss rates of entire pregnancies after assisted reproduction are lower in twin than in singleton pregnancies  Alexandra Matias, M.D., Giovanni B.
Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial 
Medical treatment of ectopic pregnancy: a committee opinion
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Live birth of twins derived from zona-free oocytes
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.
Oocyte cryopreservation
Two interesting cases of ovarian pregnancy after in vitro fertilization–embryo transfer and its successful laparoscopic management  Selvaraj Priya, M.D.,
Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation  Amanda.
Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis  Cui Hong Zheng, M.D., Ph.D.,
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer  Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
Amir M. Khan, M. D. , Sunit Jariwala, M. D. , Harry Jay Lieman, M. D
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
A prospective study of early pregnancy loss in humans
Fewer than 9 days of estrogen exposure prior to progesterone initiation results in lower pregnancy rates in programmed frozen embryo transfer cycles 
Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged.
Maternal complication of cervical heterotopic pregnancy after successful potassium chloride fetal reduction  Cynthia Gyamfi, M.D., Samantha Cohen, B.A.,
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles  Karin.
Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above  Sigal Klipstein, M.D., Meredith.
Protein Z levels and unexplained fetal losses
Aaron K. Styer, M. D. , Diane L. Wright, Ph. D. , H. C. L. D. , Anne M
Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success  J. Ryan Martin, M.D., Jason G. Bromer,
Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.
Progesterone level at oocyte retrieval predicts in vitro fertilization success in a short- antagonist protocol: a prospective cohort study  Shweta Nayak,
Brian W. Whitcomb, Ph. D. , Enrique F. Schisterman, Ph. D. , Mark A
Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind,
Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?  Luis.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
Relaxin has a role in establishing a renal response in pregnancy
Fertility and Sterility: an evaluation
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study  Laurel Stadtmauer, M.D.,
Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B
Current evaluation of amenorrhea
The play of chance Fertility and Sterility
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles  Inna Berin, M.D., Lawrence L. Engmann, M.D., Claudio.
Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists 
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Treatment of heterotopic cervical pregnancy after in vitro fertilization–embryo transfer by using transvaginal ultrasound–guided aspiration and instillation.
Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation  Reshef.
Randomized controlled trial: effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization  Irene Moy, M.D., Magdy P. Milad, M.D.,
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Daniel R. Grow, M.D., Khosro Iromloo, M.D.  Fertility and Sterility 
Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation  Janet F. McLaren, M.D., Richard O. Burney,
Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles 
Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society.
Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles  John L. Frattarelli,
Presentation transcript:

Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization–embryo transfer  Mohamed F. Mitwally, M.D., H.C.L.D., Michael P. Diamond, M.D., Mostafa Abuzeid, M.D.  Fertility and Sterility  Volume 93, Issue 2, Pages 554-569 (January 2010) DOI: 10.1016/j.fertnstert.2009.02.047 Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Mean serum P levels during the luteal phase (all women) and early weeks of gestation (pregnant women) in the vaginal P group and in the IM-P4 group. Serum P levels are presented as mean ± SEM. During the luteal phase, the mean serum P level on days 9 and 10 after oocyte retrieval was statistically significantly higher in the IM-P4 group. However, during early pregnancy, serum P levels were statistically significantly higher in the vaginal P group on mean days (after oocyte retrieval) of 19–22, 23–26, and 27days to 12 weeks of gestation. Fertility and Sterility 2010 93, 554-569DOI: (10.1016/j.fertnstert.2009.02.047) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Mean P levels throughout the luteal phase (first 18 days after oocyte retrieval) in all women and throughout early pregnancy phase (18 days after oocyte retrieval until 12 weeks of gestation) in pregnant women. Data are presented as the mean ± SEM. While overall the mean serum P level was not different during the luteal phase, it was statistically higher in the vaginal P group during the early pregnancy phase. Fertility and Sterility 2010 93, 554-569DOI: (10.1016/j.fertnstert.2009.02.047) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Mean serum P levels during the luteal phase (only pregnant women) and early weeks of gestation in the vaginal P group and in the IM-P4 group. Serum P levels are presented as mean ± SEM. During the luteal phase, mean serum P levels were not statistically different between the vaginal P group and the IM-P4 group. However, during early pregnancy, serum P levels were statistically significantly higher in the vaginal P group on mean days (after oocyte retrieval) of 19–22, 23–26, and 27 days to 12 weeks of gestation. Fertility and Sterility 2010 93, 554-569DOI: (10.1016/j.fertnstert.2009.02.047) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 4 Mean P levels throughout the luteal phase (first 18 days after oocyte retrieval) in pregnant women and throughout early pregnancy phase (18 days after oocyte retrieval until 12 weeks of gestation) in pregnant women. Data are presented as the mean ± SEM. While overall the mean serum P level was not different during the luteal phase, it was statistically higher in the vaginal P group during the early pregnancy phase. Fertility and Sterility 2010 93, 554-569DOI: (10.1016/j.fertnstert.2009.02.047) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 5 Mean serum P levels during the luteal phase (nonpregnant women) in the vaginal P group and in the IM-P4 group. Serum P levels are presented as mean ± SEM. Mean serum P levels were consistently higher in the IM-P4 group. However, the difference was not statistically insignificant except the mean level on day 9–10 that was significantly lower in the vaginal P group. Fertility and Sterility 2010 93, 554-569DOI: (10.1016/j.fertnstert.2009.02.047) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 6 Mean P levels throughout the luteal phase (first 18 days after oocyte retrieval) in nonpregnant women. Data are presented as the mean ± SEM. Overall the mean serum P level was not statistically different between the vaginal P group and the IM-P4 group during the luteal phase. Fertility and Sterility 2010 93, 554-569DOI: (10.1016/j.fertnstert.2009.02.047) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions